Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis B Reactivation”

41 trials

Showing 20 of 41 results

Not applicableStudy completedNCT06114251
What this trial is testing

Hepatitis B Virus Reactivation: a Cautionary Event After Liver Transplantation for Patients With Hepatocellular Carcinoma

Who this might be right for
Liver Transplant; Complications
Zhejiang University 920
Not applicableStudy completedNCT01481649
What this trial is testing

Risk of Hepatitis B Reactivation After Bone Marrow Transplantation With Prior Hepatitis B Virus (HBV) Exposure

Who this might be right for
Exposure to Hepatitis B Virus
The University of Hong Kong 69
Testing effectiveness (Phase 2)UnknownNCT01914744
What this trial is testing

Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL

Who this might be right for
Non-Hodgkin LymphomaHepatitis B Reactivation
Fudan University 82
Not applicableUnknownNCT00931229
What this trial is testing

Incidence of Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients

Who this might be right for
Non-Hodgkin's Lymphoma
National Health Research Institutes, Taiwan 202
Not applicableUnknownNCT00489151
What this trial is testing

Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy

Who this might be right for
Hepatitis B
Hospital Authority, Hong Kong 70
Not applicableStudy completedNCT01311232
What this trial is testing

Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab

Who this might be right for
Patients With Diffuse Large B-cell Lymphoma or Follicular LymphomaPatients Treated With Rituximab-CHOP or Rituximab-CVP
Samsung Medical Center 600
Post-approval studies (Phase 4)Study completedNCT02081469
What this trial is testing

Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy

Who this might be right for
Hepatitis B, ChronicTumor
Chang Gung Memorial Hospital 100
Not applicableStudy completedNCT02108444
What this trial is testing

Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients

Who this might be right for
HepatitisHepatitis BLymphoma+1 more
Peking University 107
Post-approval studies (Phase 4)Active Not RecruitingNCT04619082
What this trial is testing

TAF to Prevent HBV Reactivation in Cancer Patients

Who this might be right for
Hepatitis B Reactivation
Chiayi Christian Hospital 102
Large-scale testing (Phase 3)UnknownNCT02186574
What this trial is testing

Tenofovir to Prevent HBV Reactivation

Who this might be right for
Hepatitis BLymphomaNon-Hodgkin
University Health Network, Toronto 184
Not applicableUnknownNCT05768061
What this trial is testing

HBV Reactivation in Anti CD20 Treatment

Who this might be right for
Hepatitis B
HaEmek Medical Center, Israel 5,000
Not applicableNot Yet RecruitingNCT06728917
What this trial is testing

Occult Hepatitis B Virus Infection and HBV Reactivation After Switching to Long Acting Therapy in Patients With HIV-1

Who this might be right for
HBV (Hepatitis B Virus)HIV Infection
IRCCS San Raffaele 50
Not applicableUnknownNCT03529760
What this trial is testing

Chemotherapy Efficacy and Follow-up Study of Hepatitis B Virus Infection and Reactivation in Children With Leukemia

Who this might be right for
Reactivation of Hepatitis B Virus
Children's Hospital of Chongqing Medical University 600
Testing effectiveness (Phase 2)Ended earlyNCT03804372
What this trial is testing

The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir Alafenamide

Who this might be right for
Large-B-cell Diffuse LymphomaChronic Lymphoid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 5
Not applicableStudy completedNCT03528941
What this trial is testing

The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib

Who this might be right for
Chronic Lymphocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 109
Not applicableUnknownNCT04680598
What this trial is testing

Comparison of HBV Reactivation Between Patients With High HBV-DNA and Low HBV-DNA Loads Undergoing ICI and Concurrent Antiviral Prophylaxis: a Prospective Observational Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 800
Large-scale testing (Phase 3)UnknownNCT01210287
What this trial is testing

Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP

Who this might be right for
Lymphoma
Fudan University 110
Not applicableStudy completedNCT00876148
What this trial is testing

Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting

Who this might be right for
Hepatitis B VirusAllograftHematological Malignancies
Azienda Ospedaliera San Giovanni Battista
Testing effectiveness (Phase 2)UnknownNCT04442841
What this trial is testing

HBV Vaccine in Anti-core Positive Donors After LT

Who this might be right for
Hepatitis B Reactivation
Hospital Clinic of Barcelona 114
Not applicableStudy completedNCT02689245
What this trial is testing

Randomized Controlled Trial Comparing the Efficacy and Safety of FMT in Hepatitis B Reactivation Leads to Acute on Chronic Liver Failure.

Who this might be right for
Acute on Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 64
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation